Robert E Claypoole

Director, President and CEO · 1 filing · Latest: Mar 14, 2025

Bioventus Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
BVS	Robert E Claypoole	Director, President and CEO	Mar 13, 2026	Option Exercise	$0.00	33,500	—	150,497	Mar 17 9:00 PM
BVS	Claypoole Robert E	—	Jan 13, 2025	Proposed Sale	$9.55	33,000	$315.1K	—	Jan 14 2:16 AM